FANJ
SNOA icon

Financial Architects (New Jersey)’s Sonoma Pharmaceuticals SNOA Stock Holding History

Financial Architects (New Jersey)’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7
Closed -$9K – 798
2015
Q2 		$9K Buy
+7
New +$6.56K ﹤0.01% 825

Other funds holding SNOA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Architects (New Jersey)'s SNOA Position: Q3 2015 in Review

Financial Architects (New Jersey) sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2015, closing a stake of 7 shares — an estimated $9K sold.

Financial Architects (New Jersey) first reported a position in SNOA in Q2 2015 and held it in 1 quarter. The position peaked at $9K in Q2 2015. 16 funds tracked by Wall St. Rank hold SNOA as of Q3 2015.

  • Financial Architects (New Jersey) reported no remaining Sonoma Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 7 Sonoma Pharmaceuticals shares in Q3 2015, an estimated $9K.
  • Financial Architects (New Jersey) first reported a position in Sonoma Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s Sonoma Pharmaceuticals position peaked at $9K in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2015.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2015, filed 13 Nov 2015.